SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SALVADORI, Severo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.488
EU - Europa 4.029
AS - Asia 3.055
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AF - Africa 2
Totale 24.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.462
CN - Cina 1.624
UA - Ucraina 1.253
TR - Turchia 826
DE - Germania 793
IT - Italia 582
GB - Regno Unito 568
SG - Singapore 525
SE - Svezia 314
FI - Finlandia 298
BE - Belgio 59
FR - Francia 52
PL - Polonia 35
CA - Canada 26
IR - Iran 20
IN - India 18
RU - Federazione Russa 17
CZ - Repubblica Ceca 14
BR - Brasile 13
NL - Olanda 11
ID - Indonesia 10
CO - Colombia 7
HK - Hong Kong 7
KR - Corea 7
RO - Romania 7
AT - Austria 5
CL - Cile 5
EU - Europa 5
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
VN - Vietnam 3
AU - Australia 2
DK - Danimarca 2
GR - Grecia 2
IE - Irlanda 2
JP - Giappone 2
NO - Norvegia 2
NP - Nepal 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
ES - Italia 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MM - Myanmar 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 24.613
Salva come PNG Salva come JPEG
Città #
Fairfield 2.354
Woodbridge 2.335
Houston 1.563
Jacksonville 1.424
Ann Arbor 1.246
Ashburn 1.160
Chandler 1.099
Seattle 893
Wilmington 841
Cambridge 786
Izmir 436
Nanjing 410
Singapore 365
Beijing 322
Princeton 275
San Diego 230
Boardman 196
Dearborn 196
Milan 164
Ferrara 145
Nanchang 118
Shenyang 116
Shanghai 99
Los Angeles 90
Addison 89
New York 88
Falls Church 81
San Mateo 75
Hebei 71
Auburn Hills 65
Jiaxing 63
Bremen 62
Jinan 61
Changsha 58
Santa Clara 58
Tianjin 56
Brussels 54
Mountain View 49
Kunming 47
Munich 47
Redwood City 41
Helsinki 40
Washington 38
Philadelphia 37
Zhengzhou 37
Norwalk 35
Ningbo 34
Warsaw 34
London 31
Tappahannock 24
Des Moines 22
Mcallen 22
Guangzhou 21
Orange 21
Indiana 19
Montréal 17
Hefei 15
Bologna 14
Taizhou 14
Augusta 13
Leawood 12
Redmond 12
Verona 12
Lanzhou 11
Ardabil 10
Düsseldorf 10
Jakarta 10
Prescot 9
Hounslow 8
Kilburn 8
Medellín 7
Changchun 6
Chicago 6
Florence 6
Hangzhou 6
Hong Kong 6
Olomouc 6
Bari 5
Brno 5
Chiswick 5
Haikou 5
New Bedfont 5
Osasco 5
San Francisco 5
Walnut 5
Ferrara di Monte Baldo 4
Fuzhou 4
Padova 4
Yellow Springs 4
Amsterdam 3
Innsbruck 3
Islington 3
La Canada Flintridge 3
Monmouth Junction 3
Mumbai 3
Portici 3
Rome 3
San Giorgio delle Pertiche 3
Toronto 3
Wandsworth 3
Totale 18.650
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 200
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 171
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 166
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 164
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 160
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 151
Physicochemical stability of cabazitaxel and docetaxel solutions 147
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 146
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 141
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 140
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 140
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 139
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 138
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 136
A new selective antagonist of the nociceptin receptor 136
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 134
Pharmacological characterization of nociceptin receptor: an in vitro study 133
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 132
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 130
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 130
null 130
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 128
A new ligand for the urotensin II receptor 128
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 127
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 126
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 126
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 126
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 125
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 123
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 123
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 122
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 122
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 122
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 122
null 121
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 121
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 120
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 119
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 119
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 118
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 117
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 116
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 116
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 115
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 115
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 115
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 115
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 114
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 113
Critical role for prokineticin 2 in CNS autoimmunity 113
Pharmacological characterization of tachykinin tetrabranched derivatives 113
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 112
Structure-activity study at positions 3 and 4 of human neuropeptide S. 112
Design of d-opioid peptide antagonists for emerging drug applications 112
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 111
Synthesis and antimicrobial activity of dermaseptin S1 analogues 111
Dermorphin inhibits spinal nociceptive flexion reflex in humans 111
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 111
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 110
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 110
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 110
Role of benzimidazole (Bid) in the d-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH2-Bid (UFP-502) 110
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 110
null 110
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 109
Structure-activity relationships of cyclic and linear peptide T analogues. 109
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 109
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 109
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 108
Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt]deltorphin B 108
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 108
Single Diastereomeric Desaminotyrosylalanyl Tetra- and Heptapeptides with Opioid Antagonistic Activity 108
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 108
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 108
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 107
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 107
Neuropeptide S receptor ligands: a patent review (2005-2016) 107
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 107
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 107
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 106
null 106
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 106
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 105
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 105
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 105
Synthesis and biological activity of carboxyl terminally extended dermorphins. 104
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: A randomized, placebo-controlled, double-blind study 104
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 103
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 103
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds 103
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 103
null 103
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 103
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 102
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 102
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 102
Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders. 101
Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats 101
Totale 11.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.632
Totale 106.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.595 0 0 0 848 407 730 594 634 455 574 226 127
2020/20213.418 305 343 144 468 134 366 112 407 84 416 469 170
2021/20222.981 126 290 230 211 227 133 136 170 113 227 223 895
2022/20232.728 296 96 90 335 463 379 148 270 387 16 143 105
2023/20241.289 150 181 94 32 103 233 51 82 17 22 32 292
2024/2025655 140 106 409 0 0 0 0 0 0 0 0 0
Totale 24.872